Abstract
National working group representing clinicians (hematologists, oncologists, infection diseases and ICU specialists...), microbiologists, and different special medical societies and working groups prepared evidence-based guidelines for the treatment established fungal infection – invasive candidiasis in the adult hematology and ICU patients. These guidelines updated those published in the Czech Republic in 2003/2004.
Evidence criteria of the Infectious Diseases Society of America (IDSA) were used for assessing the quality of clinical trials, and EORTC/MSG Consensus Group for definitions of invasive fungal disease.